EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Population Pharmacokinetic Model for the Use of Intravenous or Subcutaneous Infliximab in Patients with Inflammatory Bowel Disease: Real-World Data from a Prospective Cohort Study

Joo Hye Song iD, Sung Noh Hong iD, Myeong Gyu Kim iD, Minjung Kim iD, Seong Kyung Kim iD, Eun Ran Kim iD, Dong Kyung Chang iD, Young-Ho Kim iD

Gut and Liver · 15.05.2025 · 19 (3) · 376-387

DOI: 10.5009/gnl240503 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Gut and Liver, online erschienen am 21.04.2025. Verfasst von Joo Hye Song und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Infliximab, Gastrointestinal Agents, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean Society of Gastroenterology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InfliximabGastrointestinal AgentsInflammatory Bowel DiseasesHumansProspective StudiesFemaleMaleAdultMiddle AgedInjections, SubcutaneousAdministration, IntravenousModels, BiologicalColitis, UlcerativeC-Reactive ProteinAged

Stichwörter der Autor:innen

Inflammatory bowel diseasesInfliximabIntravenousPharmacokinetic modelSubcutaneous

Substanzen

InfliximabGastrointestinal AgentsC-Reactive Protein

Autor:innen und Institutionen

  • Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.
  • Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Korea.

ORCID-Profile: Joo Hye Song, Sung Noh Hong, Myeong Gyu Kim, Minjung Kim, Seong Kyung Kim, Eun Ran Kim, Dong Kyung Chang, Young-Ho Kim

Förderung

  • Korean Society of Gastroenterology

Zitieren

APA

Song, J. H., Hong, S. N., Kim, M. G., Kim, M., Kim, S. K., Kim, E. R., Chang, D. K., & Kim, Y. H. (2025). Population Pharmacokinetic Model for the Use of Intravenous or Subcutaneous Infliximab in Patients with Inflammatory Bowel Disease: Real-World Data from a Prospective Cohort Study. Gut and Liver, 19(3), 376-387. https://doi.org/10.5009/gnl240503

Vancouver

Song JH, Hong SN, Kim MG, Kim M, Kim SK, Kim ER, et al. Population Pharmacokinetic Model for the Use of Intravenous or Subcutaneous Infliximab in Patients with Inflammatory Bowel Disease: Real-World Data from a Prospective Cohort Study. Gut and Liver. 2025;19(3):376-387. doi:10.5009/gnl240503

BibTeX
@article{Song2025,
  author = {Song, Joo Hye and Hong, Sung Noh and Kim, Myeong Gyu and Kim, Minjung and Kim, Seong Kyung and Kim, Eun Ran and Chang, Dong Kyung and Kim, Young-Ho},
  title = {Population Pharmacokinetic Model for the Use of Intravenous or Subcutaneous Infliximab in Patients with Inflammatory Bowel Disease: Real-World Data from a Prospective Cohort Study},
  journal = {Gut and Liver},
  year = {2025},
  volume = {19},
  number = {3},
  pages = {376--387},
  doi = {10.5009/gnl240503}
}
Kostenlos starten →